Search Results - "Bago, R"

Refine Results
  1. 1

    Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy by Haney, Matthew J., Zhao, Yuling, Jin, Yeon S., Li, Samuel M., Bago, Juli R., Klyachko, Natalia L., Kabanov, Alexander V., Batrakova, Elena V.

    Published in Journal of neuroimmune pharmacology (01-09-2020)
    “…Efficient targeted delivery of anticancer agents to TNBC cells remains one of the greatest challenges to developing therapies. The lack of tumor-specific…”
    Get full text
    Journal Article
  2. 2

    Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model by Okolie, Onyinyechukwu, Bago, Juli R, Schmid, Ralf S, Irvin, David M, Bash, Ryan E, Miller, C Ryan, Hingtgen, Shawn D

    Published in Neuro-oncology (Charlottesville, Va.) (01-12-2016)
    “…Surgical resection is a universal component of glioma therapy. Little is known about the postoperative microenvironment due to limited preclinical models…”
    Get full text
    Journal Article
  3. 3

    Intercellular Mitochondrial Transfer in the Tumor Microenvironment by Sahinbegovic, Hana, Jelinek, Tomas, Hrdinka, Matous, Bago, Juli R., Turi, Marcello, Sevcikova, Tereza, Kurtovic-Kozaric, Amina, Hajek, Roman, Simicek, Michal

    Published in Cancers (04-07-2020)
    “…Cell-to-cell communication is a fundamental process in every multicellular organism. In addition to membrane-bound and released factors, the sharing of…”
    Get full text
    Journal Article
  4. 4

    Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection by Okolie, Onyinyechukwu, Irvin, David M, Bago, Juli R, Sheets, Kevin, Satterlee, Andrew, Carey-Ewend, Abigail G, Lettry, Vivien, Dumitru, Raluca, Elton, Scott, Ewend, Matthew G, Miller, C Ryan, Hingtgen, Shawn D

    Published in PloS one (10-07-2018)
    “…Cytotoxic neural stem cells (NSCs) have emerged as a promising treatment for Medulloblastoma (MB), the most common malignant primary pediatric brain tumor. The…”
    Get full text
    Journal Article
  5. 5

    Engineered Mesenchymal Stem Cell/Nanomedicine Spheroid as an Active Drug Delivery Platform for Combinational Glioblastoma Therapy by Suryaprakash, Smruthi, Lao, Yeh-Hsing, Cho, Hyeon-Yeol, Li, Mingqiang, Ji, Ha Yeun, Shao, Dan, Hu, Hanze, Quek, Chai Hoon, Huang, Dantong, Mintz, Rachel L, Bagó, Juli R, Hingtgen, Shawn D, Lee, Ki-Bum, Leong, Kam W

    Published in Nano letters (13-03-2019)
    “…Mesenchymal stem cell (MSC) has been increasingly applied to cancer therapy because of its tumor-tropic capability. However, short retention at target tissue…”
    Get full text
    Journal Article
  6. 6

    Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma by Bagó, Juli R., Alfonso-Pecchio, Adolfo, Okolie, Onyi, Dumitru, Raluca, Rinkenbaugh, Amanda, Baldwin, Albert S., Miller, C. Ryan, Magness, Scott T., Hingtgen, Shawn D.

    Published in Nature communications (02-02-2016)
    “…Transdifferentiation (TD) is a recent advancement in somatic cell reprogramming. The direct conversion of TD eliminates the pluripotent intermediate state to…”
    Get full text
    Journal Article
  7. 7

    Tumor-homing cytotoxic human induced neural stem cells for cancer therapy by Bagó, Juli R, Okolie, Onyi, Dumitru, Raluca, Ewend, Matthew G, Parker, Joel S, Werff, Ryan Vander, Underhill, T Michael, Schmid, Ralf S, Miller, C Ryan, Hingtgen, Shawn D

    Published in Science translational medicine (01-02-2017)
    “…Engineered neural stem cells (NSCs) are a promising approach to treating glioblastoma (GBM). The ideal NSC drug carrier for clinical use should be easily…”
    Get more information
    Journal Article
  8. 8

    Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma by Bagó, Juli R, Pegna, Guillaume J, Okolie, Onyi, Mohiti-Asli, Mahsa, Loboa, Elizabeth G, Hingtgen, Shawn D

    Published in Biomaterials (01-06-2016)
    “…Abstract Engineered stem cell (SC)-based therapy holds enormous promise for treating the incurable brain cancer glioblastoma (GBM). Retaining the cytotoxic SCs…”
    Get full text
    Journal Article
  9. 9

    Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer by Bagó, Juli R, Pegna, Guillaume J, Okolie, Onyi, Hingtgen, Shawn D

    Published in Biomaterials (01-04-2016)
    “…Abstract Tumor-homing cytotoxic stem cell (SC) therapy is a promising new approach for treating the incurable brain cancer glioblastoma (GBM). However,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro Assessment by Motais, Benjamin, Charvátová, Sandra, Walek, Zuzana, Hájek, Roman, Bagó, Juli R

    Published in Cells (Basel, Switzerland) (30-11-2023)
    “…Multiple myeloma (MM) has witnessed improved patient outcomes through advancements in therapeutic approaches. Notably, allogeneic stem cell transplantation,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo by Roura, Santiago, Bagó, Juli R, Soler-Botija, Carolina, Pujal, Josep M, Gálvez-Montón, Carolina, Prat-Vidal, Cristina, Llucià-Valldeperas, Aida, Blanco, Jerónimo, Bayes-Genis, Antoni

    Published in PloS one (16-11-2012)
    “…Stem cell therapies are promising strategies to regenerate human injured tissues, including ischemic myocardium. Here, we examined the acquisition of…”
    Get full text
    Journal Article
  14. 14

    A bird's-eye view of cell therapy and tissue engineering for cardiac regeneration by Soler-Botija, Carolina, Bagó, Juli R., Bayes-Genis, Antoni

    Published in Annals of the New York Academy of Sciences (01-04-2012)
    “…Complete recovery of ischemic cardiac muscle after myocardial infarction is still an unresolved concern. In recent years, intensive research efforts have…”
    Get full text
    Journal Article
  15. 15

    Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients by Buckley, Andrew, Hagler, Shaye B., Lettry, Vivien, Bagó, Juli R., Maingi, Spencer M., Khagi, Simon, Ewend, Matthew G., Miller, C. Ryan, Hingtgen, Shawn D.

    Published in Molecular therapy (08-07-2020)
    “…The conversion of human fibroblasts into personalized induced neural stem cells (iNSCs) that actively seek out tumors and deliver cytotoxic agents is a highly…”
    Get full text
    Journal Article
  16. 16

    Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response by Alieva, Maria, Bagó, Juli R, Aguilar, Elisabet, Soler-Botija, Carolina, Vila, Olaia F, Molet, Joan, Gambhir, Sanjiv S, Rubio, Nuria, Blanco, Jerónimo

    Published in PloS one (17-04-2012)
    “…Genetically modified adipose tissue derived mesenchymal stromal cells (hAMSCs) with tumor homing capacity have been proposed for localized therapy of chemo-…”
    Get full text
    Journal Article
  17. 17

    Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins by Reyes, D, Ballaré, C, Castellano, G, Soronellas, D, Bagó, J R, Blanco, J, Beato, M

    Published in Oncogene (20-03-2014)
    “…Growth of breast cancers is often dependent on ovarian steroid hormones making the tumors responsive to antagonists of hormone receptors. However, eventually…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Gene expression profiling of Nm23-H2 overexpressing CAL 27 cells using DNA microarray by Herak Bosnar, M, Bago, R, Konjevoda, P, Pavelić, J

    Published in Neoplasma (2008)
    “…Nm23-H1/NDPKA and Nm23-H2/NDPKB belong to a large family of NDP kinases, group of structurally and functionally closely related enzymes. The Nm23/NDPs are…”
    Get more information
    Journal Article
  20. 20

    Novel Local "Off-the-Shelf" Immunotherapy for the Treatment of Myeloma Bone Disease by Charvátová, Sandra, Motais, Benjamin, Czapla, Justyna, Cichoń, Tomasz, Smolarczyk, Ryszard, Walek, Zuzana, Giebel, Sebastian, Hájek, Roman, Bagó, Juli R

    Published in Cells (Basel, Switzerland) (30-01-2023)
    “…Myeloma bone disease (MBD) is one of the major complications in multiple myeloma (MM)-the second most frequent hematologic malignancy. It is characterized by…”
    Get full text
    Journal Article